Healthcare provider profile · identity verified

Andrew Rogers Morrow, MD

Family Practice · GREENFIELD, IN · NPI 1689194086

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	760	216
Amlodipine Besylate	Amlodipine Besylate	490	147
Levothyroxine Sodium	Levothyroxine Sodium	388	102
Omeprazole	Omeprazole	382	115
Losartan Potassium	Losartan Potassium	353	91
Metoprolol Succinate	Metoprolol Succinate	346	89
Lisinopril	Lisinopril	334	101
Rosuvastatin Calcium	Rosuvastatin Calcium	244	73
Mounjaro	Tirzepatide	240	44
Gabapentin	Gabapentin	235	71
Tamsulosin Hcl	Tamsulosin Hcl	230	69
Metformin Hcl	Metformin Hcl	224	72
Eliquis	Apixaban	223	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	201	48
Pantoprazole Sodium	Pantoprazole Sodium	186	56
Furosemide	Furosemide	162	46
Fluoxetine Hcl	Fluoxetine Hcl	160	47
Alprazolam	Alprazolam	158	44
Alendronate Sodium	Alendronate Sodium	151	43
Hydrochlorothiazide	Hydrochlorothiazide	150	45
Duloxetine Hcl	Duloxetine Hcl	149	35
Sertraline Hcl	Sertraline Hcl	149	45
Albuterol Sulfate Hfa	Albuterol Sulfate	144	62
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	144	31
Jardiance	Empagliflozin	137	40
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	130	35
Finasteride	Finasteride	128	39
Prednisone	Prednisone	113	83
Ozempic	Semaglutide	111	28
Potassium Chloride	Potassium Chloride	110	33
Trazodone Hcl	Trazodone Hcl	102	36
Metformin Hcl Er	Metformin Hcl	99	31
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	99	29
Montelukast Sodium	Montelukast Sodium	98	28
Allopurinol	Allopurinol	93	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	93	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	30
Simvastatin	Simvastatin	93	24
Famotidine	Famotidine	92	28
Spironolactone	Spironolactone	92	23
Escitalopram Oxalate	Escitalopram Oxalate	89	26
Tizanidine Hcl	Tizanidine Hcl	85	30
Atenolol	Atenolol	83	23
Tramadol Hcl	Tramadol Hcl	83	32
Bupropion Xl	Bupropion Hcl	81	26
Hydroxyzine Hcl	Hydroxyzine Hcl	79	25
Citalopram Hbr	Citalopram Hydrobromide	78	20
Clopidogrel	Clopidogrel Bisulfate	74	24
Doxazosin Mesylate	Doxazosin Mesylate	74	18
Metoprolol Tartrate	Metoprolol Tartrate	72	19
Venlafaxine Hcl Er	Venlafaxine Hcl	71	14
Nifedipine Er	Nifedipine	68	19
Ramipril	Ramipril	68	18
Meloxicam	Meloxicam	67	21
Pravastatin Sodium	Pravastatin Sodium	67	18
Trulicity	Dulaglutide	67	16
Diclofenac Sodium	Diclofenac Sodium	65	20
Synthroid	Levothyroxine Sodium	64	17
Glimepiride	Glimepiride	63	22
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	63	13
Carvedilol	Carvedilol	61	17
Memantine Hcl	Memantine Hcl	61	14
Xarelto	Rivaroxaban	59	18
Pregabalin	Pregabalin	56	19
Celecoxib	Celecoxib	55	23
Cephalexin	Cephalexin	54	42
Ezetimibe	Ezetimibe	53	16
Ropinirole Hcl	Ropinirole Hcl	53	13
Ondansetron Odt	Ondansetron	52	28
Fluticasone Propionate	Fluticasone Propionate	51	24
Esomeprazole Magnesium	Esomeprazole Magnesium	50	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	50	22
Topiramate	Topiramate	50	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	44	24
Donepezil Hcl	Donepezil Hcl	43	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	16
Paroxetine Hcl	Paroxetine Hcl	41	suppressed
Naproxen	Naproxen	39	12
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	38	13
Chlorthalidone	Chlorthalidone	37	13
Quetiapine Fumarate	Quetiapine Fumarate	37	13
Doxycycline Hyclate	Doxycycline Hyclate	36	25
Triamcinolone Acetonide	Triamcinolone Acetonide	35	22
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Farxiga	Dapagliflozin Propanediol	34	suppressed
Lansoprazole	Lansoprazole	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Testosterone Cypionate	Testosterone Cypionate	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	28
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	33	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Clonazepam	Clonazepam	30	11
Ipratropium Bromide	Ipratropium Bromide	30	11
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Azithromycin	Azithromycin	27	25
Estradiol	Estradiol	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	suppressed
Myrbetriq	Mirabegron	25	suppressed
Torsemide	Torsemide	25	suppressed
Fluconazole	Fluconazole	24	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Valsartan	Valsartan	24	11
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	23	23
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Baclofen	Baclofen	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	20	20
Diazepam	Diazepam	20	12
Indapamide	Indapamide	20	suppressed
Methylprednisolone	Methylprednisolone	20	18
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	18
Lovastatin	Lovastatin	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	13
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	18	14
Warfarin Sodium	Warfarin Sodium	18	suppressed
Glipizide Er	Glipizide	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Junel	Norethindrone Ac/Eth Estradiol	17	suppressed
Linzess	Linaclotide	17	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Acyclovir	Acyclovir	15	11
Levetiracetam	Levetiracetam	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Nystatin	Nystatin	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	11
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Lorazepam	Lorazepam	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	12	12
Nitroglycerin	Nitroglycerin	12	suppressed
Armodafinil	Armodafinil	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Vraylar	Cariprazine Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error